BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 13, 2007
 |  BioCentury  |  Product Development

Cephalon's pain sales

Cephalon's pain sales

Actiq fentanyl sales grew at an average annual rate of 83% from the time Cephalon acquired the drug via its purchase of Anesta in 2000 until...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >